91¿´Æ¬

Today, the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) announced 32 coronavirus response projects to multiple organizations across the United States funded through the American Rescue Plan (ARP).

NIIMBL identified projects that will help the nation prevent, prepare for, and respond to coronavirus public health...

The U.S. Department of Commerce’s National Institute of Standards and Technology (NIST) has made two awards totaling $153 million to the (NIIMBL). The awards were announced today by U.S. Secretary of Commerce Gina Raimondo at the NIIMBL annual meeting in Washington, D.C.

NIIMBL...

The Department of Defense is announcing a request for information (RFI) to identify partnership opportunities for a new Manufacturing Innovation Institute dedicated to synthetic biology, or SynBio, for non-biomedical applications. The SynBio institute aims to deliver new capabilities by "scaling-up" critical bio-manufacturing processes and related...

The (NIIMBL), a proud member of 91¿´Æ¬Â®, is pleased to welcome Genentech, Celgene, Merck, MilliporeSigma and EMD Serono (the U.S. businesses of Merck KGaA, Darmstadt, Germany), among others, to its growing membership base.

These companies join more than 79...